Survival associated miRNA signature in patients with head and neck carcinomas
Head and neck carcinoma (HNSC) is often diagnosed at advanced stage, incurring poor patient outcome. Despite of advances in chemoradiation and surgery approaches, limited improvements in survival rates of HNSC have been observed over the last decade. Accumulating evidences have demonstrated the impo...
Main Authors: | Srinivasulu Yerukala Sathipati, Shinn-Ying Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023044262 |
Similar Items
-
Survival estimation in patients with stomach and esophageal carcinoma using miRNA expression profiles
by: Srinivasulu Yerukala Sathipati, et al.
Published: (2022-01-01) -
Identification of candidate plasma miRNA biomarkers for the diagnosis of head and neck squamous cell carcinoma
by: Weixing Liu, et al.
Published: (2023-11-01) -
Unveiling the Mechanisms Underlying the Immunotherapeutic Potential of Gene–miRNA and Drugs in Head and Neck Cancer
by: Danishuddin, et al.
Published: (2024-07-01) -
Genome‐wide identification of a novel miRNA‐based signature to predict recurrence in patients with gastric cancer
by: Yongmei Yang, et al.
Published: (2018-12-01) -
Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer
by: Wenqian Qi, et al.
Published: (2021-02-01)